Editor-in-Chief
Hatice Kübra Elçioğlu
Vice Editors
Levent Kabasakal
Esra Tatar
Online ISSN
2630-6344
Publisher
Marmara University
Frequency
Bimonthly (Six issues / year)
Abbreviation
J.Res.Pharm.
Former Name
Marmara Pharmaceutical Journal
Journal of Research in Pharmacy
2024 , Vol 28 , Issue 4
The evaluation of the protective effect of ambroxol against acetaminophen-induced hepatorenal toxicity in rats
1Department of Biochemistry, Faculty of Veterinary Medicine, Near East University, Nicosia, North Cyprus, Mersin- 10 Türkiye2Department of Histology and Embryology, Faculty of Veterinary Medicine, Near East University, Nicosia, North Cyprus, Mersin-10 Türkiye
3Department of Histology and Embryology, Faculty of Veterinary Medicine, Siirt University, Siirt, Türkiye
4Department of Pharmacology, Faculty of Dentistry, Near East University, Nicosia, North Cyprus, Mersin-10 Türkiye DOI : 10.29228/jrp.802 Acetaminophen (APAP), widely used as an analgesic-antipyretic drug, can cause liver and kidney damage at high doses. This study explored the protective effects of a mucolytic agent and an antioxidant Ambroxol (AMB), against APAP-induced toxicity in rats. The experiment included four groups of Wistar albino rats each having 6 animals in both sexes: a control group, an AMB-only group (50 mg/kg orally), an APAP-only group (1000 mg/kg intraperitoneally), and a combination APAP+AMB group. Twenty-four hours following the administration of APAP administration, rats were sacrificed. Measurements of blood levels of liver enzymes (AST, ALT, ALP, LDH), kidney function markers (Urea, Creatinine), and antioxidant enzymes (SOD, GPx) were performed. GPx and SOD activities were also assessed in hepatic and renal tissue samples. Histological examination of hepatic and renal tissues was conducted using Haematoxylin and Eosin staining. Results showed that APAP significantly increased liver enzymes, BUN, and Creatinine levels, indicating hepatorenal damage. This was accompanied by a decrease in plasma GPx and SOD activities. However, AMB treatment significantly mitigated these changes. It improved enzyme activities and increased hepatic GPx. Histologically, the APAP group showed liver cell damage, necrosis, haemorrhage, and inflammation, which were notably reduced in the AMB-treated group. This study suggests that Ambroxol effectively counters APAPinduced hepatorenal damage by restoring antioxidant enzyme levels and normalizing functional enzyme activities, highlighting its potential as a protective agent. Keywords : Acetaminophen; Ambroxol; Glutathione peroxidase; Superoxide dismutase; Liver, Kidney